After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
JNJ belongs to the Healthcare sector of the NYSE while operating in the Drug Manufacturers – General industry. The current market capitalization of Johnson & Johnson is $402.82B. A total of 6.17 million shares were traded on the day, compared to an average of 8.28M shares.
In the most recent transaction, REED JOHN C sold 19,137 shares of JNJ for 163.55 per share on Jul 17 ’25. After the transaction, the EVP, Innovative Medicine, R&D now owns 10,658 company shares. In a previous transaction on Jul 17 ’25, REED JOHN C bought 19,137 shares at 163.55 per share.
Among the insiders who sold shares, Decker Robert J disposed of 6,999 shares on Feb 25 ’25 at a per-share price of $165.88. This resulted in the VP Corporate Controller holding 21,001 shares of JNJ after the transaction. In another insider transaction, Decker Robert J bought 6,999 shares at $165.88 per share on Feb 25 ’25.
Dividend
Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Johnson & Johnson pays an annual dividend of $5.02, resulting in a dividend yield of 3.00%, and it has a price to earnings (P/E) ratio of 17.89.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, JNJ has a high of $169.99 and a low of $140.68.
As of this writing, JNJ has an earnings estimate of $2.75 per share for the current quarter. EPS was calculated based on a consensus of 18.0 estimates, with a high estimate of $2.9 per share and a lower estimate of $2.63.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. JNJ’s latest balance sheet shows that the firm has $31.61B in Cash & Short Term Investments as of fiscal 2021. There were $33.75B in debt and $45.23B in liabilities at the time. Its Book Value Per Share was $32.60, while its Total Shareholder’s Equity was $74.02B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
